Overview: MedPlus Health Services Limited operates in India as a retailer of medicines and general items, with a market cap of ₹76.36 billion.
Operations: The company's revenue primarily comes from its retail segment, which generated ₹57.43 billion, complemented by its diagnostics segment with ₹852.29 million.
Insider Ownership: 13.5%
Earnings Growth Forecast: 41.8% p.a.
MedPlus Health Services is poised for significant earnings growth at 41.8% annually, surpassing the Indian market's average. Despite this, its return on equity is forecasted to remain low at 11%. Revenue growth of 16.7% also exceeds market expectations but remains below a high-growth threshold. Recent regulatory challenges could impact operations slightly, with potential revenue losses totaling INR 1.334 million from temporary store suspensions in Maharashtra and Andhra Pradesh.